Vanguard Capital Wealth Advisors’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,175
| Closed | -$22K | – | 132 |
|
|
2022
Q3 | $22K | Sell |
3,175
-723
| -19% | -$5.01K | 0.03% | 112 |
|
|
2022
Q2 | $41K | Sell |
3,898
-75
| -2% | -$789 | 0.05% | 125 |
|
|
2022
Q1 | $86K | Hold |
3,973
| – | – | 0.06% | 147 |
|
|
2021
Q4 | $111K | Sell |
3,973
-6,975
| -64% | -$195K | 0.08% | 141 |
|
|
2021
Q3 | $457 | Buy |
10,948
+7,823
| +250% | +$327 | 0.31% | 76 |
|
|
2021
Q2 | $248K | Buy |
+3,125
| New | +$248K | 0.19% | 118 |
|